RxDoctor Payments Data

Shannon Cornell, NP

Adult Health · Charleston, SCNPI 1679951990

Payments from drug & device makers

$2,334in general payments, 2019–2025

Across 64 payments — averaging $36.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$996
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$277
  • Cvrx, Inc.$266
  • Abbott$231
  • Endotronix, Inc.$155
  • Boston Scientific$139
  • plus $269 from 5 others

What the payments were for

  • Travel & lodging$733%
  • Food & beverage$2,26197%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,334 in reported general payments places this provider in the 65th percentile of 292 adult health providers in South Carolina.

See all adult health providers in South Carolina

Medicare billing

Part B allowed, 2024
$47,095
Medicare patients
201
Services billed
690

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis33$866,569
EntrestoSacubitril/Valsartan523$467,693
JardianceEmpagliflozin257$235,478
FarxigaDapagliflozin Propanediol291$222,762
EliquisApixaban125$106,836
MounjaroTirzepatide14$17,557
XareltoRivaroxaban16$14,970
LokelmaSodium Zirconium Cyclosilicate12$8,687
Bumetanide190$8,549
Metoprolol Succinate352$5,202
Spironolactone436$2,643
Eplerenone30$2,501
Furosemide287$1,521
Losartan Potassium170$1,354
Atorvastatin Calcium159$1,344

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$60$235,478257 claims
AstraZenecaFarxiga, Lokelma$65$231,449303 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 292 adult health providers in South Carolina.

Other adult health in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →